Spatial distribution and multilevel analysis of factors associated with long-acting reversible contraceptive use among sexually active women of reproductive age in Nigeria.

DHS Long-acting reversible contraceptive use Multilevel analysis Nigeria Spatial analysis

Journal

Archives of public health = Archives belges de sante publique
ISSN: 0778-7367
Titre abrégé: Arch Public Health
Pays: England
ID NLM: 9208826

Informations de publication

Date de publication:
02 Jun 2023
Historique:
received: 14 05 2022
accepted: 16 05 2023
medline: 3 6 2023
pubmed: 3 6 2023
entrez: 2 6 2023
Statut: epublish

Résumé

Long-acting reversible contraceptives (LARCs), including hormonal implants and intrauterine devices, are highly effective pregnancy prevention methods. Aside its advantages over other hormonal methods, LARCs are cost-effective, easy to maintain, and have a low risk of non-compliance-related method failure. Besides, LARCs are also relatively safe for all sexually active women in the postpartum or post-abortion period. However, despite its effectiveness, most sexually active women use other short-term methods, such as condoms and contraceptive pills, which are associated with high discontinuation rates. Thus, this study examines the spatial distribution and multilevel factors associated with LARC use among sexually active reproductive-age women in Nigeria. This is a cross-sectional analysis of a population-based study from the 2018 Nigeria Demographic Health Survey (NDHS). The NDHS is a nationally representative survey that collects data on socio-demographic characteristics, sexual and reproductive health-related indicators such as contraceptive use and child & maternal health. A sample of 3,978 sexually active reproductive-age women (15-49 years) in Nigeria was used in the analysis. Frequency distribution and spatial analysis of LARC use were displayed with tables and maps, respectively, while multilevel analysis at a 95% confidence interval (CI) and a p-value of less than 0.05 was used to determine factors associated with LARC use among the sample. The spatial distribution of LARC use among sexually active women of reproductive age in Nigeria ranges between 20 and 34.8%. Fifteen of the 36 states (excluding the Federal Capital Territory, FCT) recorded low utilization of LARCs. These states include Adamawa, Lagos, Ogun, Enugu, Anambra, Imo, Abia, Rivers, Kogi, Taraba, Yobe, Gombe, Jigawa, Borno, and Kebbi. Besides, the likelihood of LARC use was lower among participants with a prior history of pregnancy termination [aOR = 0.62; 95%(CI = 0.48-0.80)] compared to their counterparts without pregnancy termination history. Also, participants with no fertility intention had a higher likelihood of using LARCs [aOR = 1.65; 95%(CI = 1.30-2.08)] compared to those with fertility intention. At the community level, women with higher socioeconomic status were less likely to use LARCs [aOR = 0.66; 95%(CI = 0.45-0.97)] compared to women with lower socioeconomic status. This study showed a relatively low utilisation of LARC among sexually active reproductive-age women in Nigeria. Notably, this low utilisation is also common in states that could be described as cosmopolitan, indicating a need for closer investigation to understand context-specific factors associated with LARC use. Population-specific family planning education and counselling for this population are important to address common misconceptions about LARCs in particular and modern contraceptive use in general.

Sections du résumé

BACKGROUND BACKGROUND
Long-acting reversible contraceptives (LARCs), including hormonal implants and intrauterine devices, are highly effective pregnancy prevention methods. Aside its advantages over other hormonal methods, LARCs are cost-effective, easy to maintain, and have a low risk of non-compliance-related method failure. Besides, LARCs are also relatively safe for all sexually active women in the postpartum or post-abortion period. However, despite its effectiveness, most sexually active women use other short-term methods, such as condoms and contraceptive pills, which are associated with high discontinuation rates. Thus, this study examines the spatial distribution and multilevel factors associated with LARC use among sexually active reproductive-age women in Nigeria.
METHODS METHODS
This is a cross-sectional analysis of a population-based study from the 2018 Nigeria Demographic Health Survey (NDHS). The NDHS is a nationally representative survey that collects data on socio-demographic characteristics, sexual and reproductive health-related indicators such as contraceptive use and child & maternal health. A sample of 3,978 sexually active reproductive-age women (15-49 years) in Nigeria was used in the analysis. Frequency distribution and spatial analysis of LARC use were displayed with tables and maps, respectively, while multilevel analysis at a 95% confidence interval (CI) and a p-value of less than 0.05 was used to determine factors associated with LARC use among the sample.
RESULTS RESULTS
The spatial distribution of LARC use among sexually active women of reproductive age in Nigeria ranges between 20 and 34.8%. Fifteen of the 36 states (excluding the Federal Capital Territory, FCT) recorded low utilization of LARCs. These states include Adamawa, Lagos, Ogun, Enugu, Anambra, Imo, Abia, Rivers, Kogi, Taraba, Yobe, Gombe, Jigawa, Borno, and Kebbi. Besides, the likelihood of LARC use was lower among participants with a prior history of pregnancy termination [aOR = 0.62; 95%(CI = 0.48-0.80)] compared to their counterparts without pregnancy termination history. Also, participants with no fertility intention had a higher likelihood of using LARCs [aOR = 1.65; 95%(CI = 1.30-2.08)] compared to those with fertility intention. At the community level, women with higher socioeconomic status were less likely to use LARCs [aOR = 0.66; 95%(CI = 0.45-0.97)] compared to women with lower socioeconomic status.
CONCLUSIONS CONCLUSIONS
This study showed a relatively low utilisation of LARC among sexually active reproductive-age women in Nigeria. Notably, this low utilisation is also common in states that could be described as cosmopolitan, indicating a need for closer investigation to understand context-specific factors associated with LARC use. Population-specific family planning education and counselling for this population are important to address common misconceptions about LARCs in particular and modern contraceptive use in general.

Identifiants

pubmed: 37269016
doi: 10.1186/s13690-023-01110-6
pii: 10.1186/s13690-023-01110-6
pmc: PMC10236581
doi:

Types de publication

Journal Article

Langues

eng

Pagination

99

Informations de copyright

© 2023. The Author(s).

Références

Am J Obstet Gynecol. 2017 Feb;216(2):101-109
pubmed: 27662799
PLoS One. 2019 Jun 4;14(6):e0217574
pubmed: 31163050
Matern Child Health J. 2017 Sep;21(9):1734-1743
pubmed: 27154524
Am J Public Health. 2016 Nov;106(11):1932-1937
pubmed: 27631741
Am J Obstet Gynecol. 2010 Aug;203(2):115.e1-7
pubmed: 20541171
Int Health. 2022 Sep 7;14(5):492-500
pubmed: 34405873
Glob Health Sci Pract. 2022 Aug 30;10(4):
pubmed: 36041833
PLoS One. 2018 Sep 18;13(9):e0203344
pubmed: 30226852
PLoS One. 2018 May 10;13(5):e0196347
pubmed: 29746475
Arch Public Health. 2022 Jan 27;80(1):43
pubmed: 35086567
N Engl J Med. 2017 Feb 2;376(5):461-468
pubmed: 28146650
Glob Health Action. 2015 Nov 09;8:29745
pubmed: 26562145
BMC Public Health. 2022 Nov 21;22(1):2141
pubmed: 36414944
J Biosoc Sci. 2014 May;46(3):294-315
pubmed: 23866105
PLoS One. 2021 Dec 8;16(12):e0258844
pubmed: 34879066
BMC Womens Health. 2017 Apr 04;17(1):25
pubmed: 28376779
Minerva Ginecol. 2013 Jun;65(3):271-7
pubmed: 23689169
Matern Health Neonatol Perinatol. 2017 Nov 07;3:19
pubmed: 29142757
Gates Open Res. 2019 Jan 14;3:7
pubmed: 32875280
BMJ Glob Health. 2020 Jan 7;5(1):e001814
pubmed: 32133166
PLoS One. 2023 Jan 20;18(1):e0279365
pubmed: 36662682
BMC Womens Health. 2021 Dec 1;21(1):399
pubmed: 34852790
BMC Pregnancy Childbirth. 2020 Jan 16;20(1):42
pubmed: 31948428
J Womens Health (Larchmt). 2022 Mar;31(3):447-457
pubmed: 34129385
Contracept Reprod Med. 2023 Jan 13;8(1):8
pubmed: 36635738
Int J Epidemiol. 2012 Dec;41(6):1602-13
pubmed: 23148108
Contraception. 2014 Mar;89(3):162-73
pubmed: 24369300

Auteurs

Obasanjo Afolabi Bolarinwa (OA)

Department of Public Health & Well-being, Faculty of Health, Medicine & Society, Chester, CH1 1SL, UK. bolarinwaobasanjo@gmail.com.
Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa. bolarinwaobasanjo@gmail.com.

Kobi V Ajayi (KV)

Department of Health Behavior, School of Public Health, Texas A&M University, College Station, TX, 77843, USA.

Sylvester Reuben Okeke (SR)

Centre for Social Research in Health, UNSW Sydney, Sydney, Australia.

Samuel Hailegebreal (S)

Department of Health Informatics, School of Public Health, College of Medicine and Health Sciences, Wachemo University, Hossana, Ethiopia.

Clifford Odimegwu (C)

Demography and Population Studies Programme, Schools of Public Health and Social Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Classifications MeSH